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Chronic implantation of surface coils on the skull has been developed to record 31P NMR spectra of the 
brain m unanesthetrzed rats. Intraperitoneal sublethal potassium cyanide doses induce strong and 
reversible changes in high-energy phosphate compounds m the brain, similar in part to those induced by 
ischemia. These effects are dose-dependent as far as phosphocreatine, inorganic orthophosphates and pH 
are concerned; ATP does not seem to be altered by KCN doses ranging from 3 to 5 mg/kg but starts 
decreasing at a dose of 6 mg/kg. The fraction of M8+ complexed ATP which could be estimated as about 
90% was not affected by KCN intoxication. For high doses (6 mg/kg) a new peak, appearing on the 
upfield side of the inorganic phosphate peak, may correspond to an acidic compartment, the significance 
of which 1s discussed. 
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1. INTRODUCTION 
Nuclear magnetic resonance (NMR) studies have 
proven their ability to track metabolic pathways 
through biochemical analyses. The development of 
surface coils [l] significantly helped application of 
these methods to in vivo studies of metabolic 
phenomena [2-81. 31P NMR spectroscopy is 
specifically able to probe high-energy phosphate 
compounds. Chronically implanted surface coils 
ensure a stable geometry of the radiofrequency coil 
with respect to the observed brain, reproducible 
throughout subsequent experiments, and provide a 
way to hold the animal in a fixed position during 
the recording session without need of anaesthesia. 
We here used 31P NMR spectroscopy with chronic 
surface coils to follow the time course of in- 
tracellular metabolic changes induced by specific 
inhibition of the respiratory chain by KCN, which 
blocks electron transport from cytochrome au3 to 
oxygen. Studies of the effects of KCN other than 
those performed on cellular or subcellular prepara- 
tions in vitro [9-131 are few. Follow-up studies of 
the spontaneous reversal of the metabolic effects 
of KCN-induced cytochrome ~1(13 blockade can on- 
ly be achieved by non-invasive methods such as 
NMR spectroscopy. 
2. MATERIALS AND METHODS 
2.1. Anrmals and surface coils 
Adult Sprague-Dawley rats (250-490 g) were 
anaesthetrzed with intraperitoneal thiopental 
(50 mg/kg) and placed on a KOPF stereotaxic 
frame and the surface coil was chronically im- 
planted (fig.1). The animals were allowed to 
recover from surgery for several days. The position 
of the surface coil with respect to the brain was 
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Frg.1. Chronically implanted surface coil. The surface coil is made of two turns of silver-coated copper wire m the 
hehcordal groove of a 20-mm diameter Teflon former (shaded area). The wire IS soldered to two pins (a) perpendrcular 
to the planes of the coil. Under general anesthesia, on a stereotaxic frame, the skull was exposed, including parietal 
surfaces. Five Teflon screws (b) were inserted into burr holes 3 mm in diameter, two m each parietal surface and the 
fifth on the midhne over the olfactory lobes. The surface coil was positioned hortzontally over the skull, its center above 
the middle pomt between lambda and bregma, the first turn of the wire being 1 mm from the skull. Dental cement (c) 
(methyl methacrylate) embeds both the screws and the cod. The skin is sutured around but not over the cod, to mimmrze 
blood contrrbutton from extracerebral components. 
kept perfectly unchanged throughout repeated ex- 
periments for periods of about 1 month. At the 
time of the experiment, the rats were briefly 
anaesthetized with diethyl ether and placed in a 
70-mm diameter home-built NMR probe fitting the 
wide bore of a 4.7 T Oxford Instruments super- 
conducting magnet. The male pins of the surface 
coil, perpendicular to the surface coil and skull 
planes, were plugged into the corresponding 
female connectors of the NMR probe. The axis of 
the surface coil was therefore kept perpendicular 
to the main axis of the supermagnet. A 19 G 
Teflon catheter was inserted into the peritoneal 
cavity, secured to the skin by a suture, and con- 
nected to a polyethylene tube, mounted on a sy- 
ringe filled with a freshly prepared KCN solution 
(3, 4, 5 or 6 mg/ml in isotonic saline). Then the 
animal, when enclosed in the probe, was allowed 
to wake up. 
2.2. NMR spectra 
The probe, containing the animal, was inserted 
2 
into the vertical wide-bore superconducting 
magnet of a Bruker CXP 200 spectrometer. Field 
homogeneity was shimmed on the proton NMR 
signal at 200 MHz. 31 P spectra were recorded at 
80.98 MHz, with a sweep width of f 4000 Hz. 
The pulse width of the radiofrequency pulses was 
40 ,US (180” at the center of the coil) [14]. Pulse 
delay was 1 s. Interpretable spectra were obtained 
within 150 s (150 scans), making it possible to 
follow the dynamics of metabolic changes with 
good temporal resolution. However, before KCN 
injection, 150-scan spectra were stored every 150 s 
over 30 min, to obtain by summation a high signal- 
to-noise ratio reference spectrum, and to assess 
statistical fluctuation of peak intensities. After in- 
traperitoneal KCN injection, spectra were stored 
every 150 s over 90 min and difference spectra bet- 
ween them and the reference were displayed. The 
broad line (=2400 Hz) due principally to the 
hydroxyapatite bound phosphorus atoms in the 
skull, but also attributed for a smaller part to the 
phospholipids m the brain [15], is removed by a 
Volume 168, number 1 FEBS LETTERS March 1984 
convolution difference technique using 400 Hz and 
40 Hz line broadenings. Further increase in resolu- 
tion is obtained if necessary by using a Gaussian 
multiplication. Chemical shifts are measured 
relative to phosphocreatine (PCr) taken as zero. 
Intracellular pH was calculated from the 
relationship 
pH = 6.66 + log P P, - 3.079 
5.57 - dP,) 
(adapted from [6]) where 6P, is the chemical shift 
of the inorganic phosphate (PJ peak. The binding 
of Mg* to ATP was calculated using the equation 
in [16], with adaptation of the constants to the rat 
body temperature (37°C). We assumed that such a 
quantitative model derived from Ehrlich ascites 
tumor cell suspensions may be legitimately used 
for calculations in the in vivo rat brain. The dif- 
ference curves presented in this study are drawn 
from the values of the intensity of each peak, 
above the zero level of the spectrum, as given by 
the spectrometer software. 
Because of the deconvolution procedures and of 
the overlapping of some peaks, we measure only 
semi-quantitative variations of the peak 
amplitudes, which is however sufficient for our 
purpose. The loss of accuracy so far introduced in 
our in vivo NMR measurements i compensated, 
from the biological point of view, by the oppor- 
tunity afforded of following the evolution of a 
metabolic phenomenon, in an animal which serves 
as its own control. 
3. RESULTS AND DISCUSSION 
3.1. Assignment of resonances of 31P spectrum in 
normal rat brain 
The normal 31P spectrum of unanaesthetized rat 
brain is shown in fig.2. Because of the broad lines 
of the in vivo spectrum, resonances from com- 
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Frg.2. 31P spectra of rat brain~during 5 mg/kg KCN experiment. After a control spectrum (900 scans), injection was 
made at t = 0, and spectra were recorded for about 100 mm. (a) Control spectrum (150 scans), (b) difference spectrum 
with control spectrum. Peak assignment* 1, sugar phosphate (SP); 2, P,; 3, glycerophosphate (GP); 4, phosphocreatine 
(PCr); 5, y-ATP; 6, cu-ATP; 7, &ATP. Each spectrum was accumulated during the time interval from to to to + 2.5 min. 
3 
Volume 168, number 1 FEBS LETTERS March 1984 
pounds of comparable chemical shifts are in- 
distinguishable from each other and participate in 
the same peak. Major 31P resonances of energy 
metabolism cellular compounds in brain have been 
identified from tissue extracts [2,1 l] and whole 
brain [ 1,2,8]. The difference in the chemical shifts 
of the &ATP resonance (2.12 ppm) between our 
observed in vivo value (- 16.24 st 0.10 ppm) and 
the value obtained from perchloric acid extracts of 
guinea pig brain (- 18.33 f 0.005 ppm) is due to 
almost total binding of ATP in vivo by Mgzf 
[ 17- 191. The proportion of uncomplexed ATP was 
found to be 11% + SD 3.4%. These values are in 
accordance with those in [17] and they may be 
compared to those calculated from perchloric acid 
extract [l I], where 88% of ATP is not complexed. 
3.2. Metabolic changes induced by intraperitoneal 
i~je&tio~ of KCN 
The dose-effect relationship was investigated 
with 3 different doses (3, 4, 5 mg/kg) in 3 groups 
of 3 animals and a 6 mg/kg dose in one animal. In 
all cases the observed changes in NMR spectra 
were of the same type: the higher the dose, the 
longer the intensity and duration of the effects. 
Qualitative aspects and time courses of typical 
changes following intrape~tone~ KCN ad- 
ministration are shown in fig.2,3. Within the first 
150 s after injection, PCr starts decreasing 
drastically while P, increases in similar propor- 
tions, as shown by difference spectra. In the mean- 
time, tissue pH decreases to about 6.7 for a 
6 mg/kg dose of KCN. Sugar phosphate and 
glycerophosphate peaks exhibit no significant 
changes at any KCN dose, while ATP, which 
decreases only for the 6 mg/kg dose, is not altered 
up to a dose of 5 mg/kg, ,which is known to pro- 
duce 75% inhibition of cytochrome oxidase activi- 
ty within 2 min 1131. The parallel experiments with 
freely moving rats injected with similar KCN doses 
show a good correspondence between the 
metabolic changes as shown by 31P spectroscopy 
and behavioral alterations. The decrease in ATP 
after a 6 mg/kg dose (fig.3) is about 30-40% of its 
control value. For lower doses (3-5 mg/kg), the 
lack of variation in ATP and ADP contrasts with 
the changes observed during brain ischemia. While 
in myocardial ischemia PCr initially decreases 
alone, and ATP and ADP are altered only later 
when PCr has almost disappeared, it has been 
4 
Fig.3. 31P spectra of rat brain durmg a 6 mg/kg KCN 
experiment. Appearance of the peak X. The resolution 
of these spectra was enhanced by Gaussian 
multiplication. Each spectrum was accumulated during 
the time interval from to to to + 10 min. 
reported [8,20] that this dissociation does not oc- 
cur during brain ischemia, where PCr and ATP 
decrease together. This difference could be ex- 
plained by the lower creatine kinase activity in 
brain (200 pmol - g-r. min-‘) than in heart 
(6OO~mol~g-’  min-‘) or by compartmentaliza- 
tion of ATP [8]. Similar effects were also observed 
during bicuculline-induced seizures 1211: PCr was 
decreased by about 50%, glycogen, glucose and 
glucose 6-phosphate decreased by more than 50%, 
while lactate increased about (i-fold, but ATP, 
ADP and AMP levels were not changed. This lack 
of variation in ATP has been recently reported 
following hypoxia and bicuculline-induced seizures 
[6]. The dose-dependent effect on ATP changes 
observed here suggests that preservation of ATP 
levels at low-dose (3-5 mglkg) KCN intoxications 
could be due either to a decrease of the backward 
flux of creatine kinase activity or to an insufficient 
impairment of cellular respiration by KCN, as 
compared to that induced by severe brain 
ischemia. This second hypothesis is in agreement 
with reported data on neonate rat brain ischemia 
where PCr and ATP fall coordinately at 37°C 
while ATP is practically constant and PCr 
decreases when ischemia is produced after reduc- 
tion of brain temperature to 20°C which reduces 
brain metabolism [22]. If it turns out to be true, 
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this could provide a convenient means for prog- 
nostic evaluation in case of human brain 
&hernia. 
After a 6 mglkg KCN injection, the Pi peak in- 
creases and shifts upfield as shown in fig.3 and a 
satellite peak (X) appears on the upfield side of the 
Pi peak. The intensity and chemical shift of this X 
peak increase as a function of time. After 30 min, 
the X peak is higher than the P, peak and its shift 
remains constant at about 3.3 ppm from the PCr 
reference. Peak X could be interpreted as a Pi peak 
corresponding to a tissue pH of 5.65, from an ex- 
tracellular compartment of lower pH than the in- 
tracellular one, or could be due to a subset of cells 
undergoing a lethal process as may be suggested by 
the death of the animal a few hours after the end 
of the experiment. This ‘dead cells hypothesis’ 
would also account for the loss of ATP which is 
observed together with the appearance of peak X. 
Another interpretation would attribute this peak to 
glycerophosphates, ranging between 3 and 4 ppm 
from the PCr reference [ll]. Whatever its origin, 
peak X seems to be related to the severity of tissue 
damage, and could therefore provide an index for 
prognostic evaluation. Additional experiments are 
required to confirm these observations and to test 
these hypotheses. 
We have shown that ‘iP NMR spectroscopy of 
the brain in vivo provides a convenient tool for 
studying changes in concentration of phospho- 
rylated metabolites following a decrease in the rate 
of oxidative phosphorylation due to an inhibition 
of cytochrome oxidase by cyanide. This tool may 
be even more useful for toxicology, given that the 
determination of brain rather than liver cyto- 
chrome c oxidase activity is significant for the 
evaluation of antidotal therapy against cyanide in- 
toxication [ 131. 
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